Physician profile
James Morley Friedman
NPI 1184063265
$7,315.43
in general payments reported to CMS, 2019-2025
11 companies · $240 in 2025
The $240 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,096 · 2020: $1,895 · 2021: $183 · 2022: $1,219 · 2023: $101 · 2024: $1,582 · 2025: $240.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $1,200 · Food and Beverage: $723.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $1,200.00 |
| Food and Beverage | $722.56 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Linvatec Corporation | $2,022.84 | 2020-2024 | Infinity Knee System, Biobrace 23mm, Livatec Knee Preservation System |
| Sequoia Surgical, INC. | $1,289.81 | 2020 | |
| Evolution Surgical, INC | $1,212.03 | 2019 | |
| Cornerstone Medical Associates, INC. | $1,200.00 | 2022 | |
| Stryker Corporation | $680.29 | 2019-2025 | Flexible Guide Pin (Stryker Acl Versitomic), Na, Flexible Guide Pin (Stryker Acl Versitomic) |
| Medical Device Business Services, INC. | $351.82 | 2019 | |
| Checkpoint Surgical, INC | $198.13 | 2025 | Checkpoint Stimulators |
| Depuy Synthes Sales INC. | $126.46 | 2019 | |
| Smith+Nephew, INC. | $103.45 | 2023-2024 | Real Intelligence, Journey II |
| Avanos Medical | $73.40 | 2021-2022 | |
| Boston Scientific Corporation | $57.20 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James Friedman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.